|
|
Volumn 288, Issue 5468, 2000, Pages 951-957
|
|
Gene therapy on trial
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GENE THERAPY;
MEDICAL ETHICS;
MEDICAL LIABILITY;
NOTE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
TOXICITY TESTING;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
FEDERAL GOVERNMENT;
FOOD AND DRUG ADMINISTRATION;
GENETICS AND REPRODUCTION;
GOVERNMENT REGULATION;
INJURIES;
NONTHERAPEUTIC RESEARCH;
RECOMBINANT DNA ADVISORY COMMITTEE;
RESEARCH SUBJECTS;
TOXICITY;
UNITED STATES;
ADENOVIRIDAE;
ADVISORY COMMITTEES;
ANIMALS;
CLINICAL TRIALS;
CYSTIC FIBROSIS;
ETHICAL REVIEW;
FEDERAL GOVERNMENT;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
GENETIC VECTORS;
GOVERNMENT REGULATION;
HUMANS;
INFLAMMATION;
INTERLEUKIN-6;
LIVER;
NATIONAL INSTITUTES OF HEALTH (U.S.);
NONTHERAPEUTIC HUMAN EXPERIMENTATION;
ORNITHINE CARBAMOYLTRANSFERASE;
RESEARCH SUBJECTS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0034640230
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.288.5468.951 Document Type: Note |
|
Times cited : (171)
|
|
References (0)
|